Tianyin Pharmaceutical Co, Inc. Reports Third Quarter Fiscal Year 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CHENGDU, China, May 14, 2013 — /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for third quarter of the fiscal year 2013.
Help employers find you! Check out all the jobs and post your resume.
CHENGDU, China, May 14, 2013 — /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for third quarter of the fiscal year 2013.
Help employers find you! Check out all the jobs and post your resume.